Molecular Interactions Stabilizing the Promatrix Metalloprotease-9·Serglycin Heteromer.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
12 Jun 2020
Historique:
received: 12 03 2020
revised: 03 06 2020
accepted: 10 06 2020
entrez: 18 6 2020
pubmed: 18 6 2020
medline: 17 2 2021
Statut: epublish

Résumé

Previous studies have shown that THP-1 cells produced an SDS-stable and reduction-sensitive complex between proMMP-9 and a chondroitin sulfate proteoglycan (CSPG) core protein. The complex could be reconstituted in vitro using purified serglycin (SG) and proMMP-9 and contained no inter-disulfide bridges. It was suggested that the complex involved both the FnII module and HPX domain of proMMP-9. The aims of the present study were to resolve the interacting regions of the molecules that form the complex and the types of interactions involved. In order to study this, we expressed and purified full-length and deletion variants of proMMP-9, purified CSPG and SG, and performed in vitro reconstitution assays, peptide arrays, protein modelling, docking, and molecular dynamics (MD) simulations. ProMMP-9 variants lacking both the FnII module and the HPX domain did not form the proMMP-9∙CSPG/SG complex. Deletion variants containing at least the FnII module or the HPX domain formed the proMMP-9∙CSPG/SG complex, as did the SG core protein without CS chains. The interacting parts covered large surface areas of both molecules and implicated dynamic and complementary ionic, hydrophobic, and hydrogen bond interactions. Hence, no short single interacting linear motifs in the two macromolecules could explain the strong SDS-stable and reduction-sensitive binding.

Identifiants

pubmed: 32545641
pii: ijms21124205
doi: 10.3390/ijms21124205
pmc: PMC7352350
pii:
doi:

Substances chimiques

Proteoglycans 0
Vesicular Transport Proteins 0
serglycin 0
MMP9 protein, human EC 3.4.24.35
Matrix Metalloproteinase 9 EC 3.4.24.35

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Acta Crystallogr D Biol Crystallogr. 2002 Jul;58(Pt 7):1182-92
pubmed: 12077439
PLoS One. 2018 Aug 3;13(8):e0200237
pubmed: 30075004
Biomed Res Int. 2014;2014:908636
pubmed: 25050378
J Mol Biol. 2000 Dec 8;304(4):669-80
pubmed: 11099388
Gene. 1990 Sep 14;93(2):235-40
pubmed: 2121613
Biol Chem. 2002 Jul-Aug;383(7-8):1059-66
pubmed: 12437088
Chin J Cancer. 2011 Sep;30(9):585-9
pubmed: 21880179
J Mol Biol. 2002 Jul 26;320(5):1065-79
pubmed: 12126625
Biochim Biophys Acta. 2014 Oct;1840(10):3162-9
pubmed: 25046380
Front Biosci. 2006 May 01;11:1696-701
pubmed: 16368548
Crit Rev Biochem Mol Biol. 2013 May-Jun;48(3):222-72
pubmed: 23547785
Am J Physiol Renal Physiol. 2012 Jun 1;302(11):F1351-61
pubmed: 22492945
Biochem J. 1995 Jul 1;309 ( Pt 1):299-306
pubmed: 7619071
Nat Protoc. 2015 Jun;10(6):845-58
pubmed: 25950237
J Biol Chem. 2000 Jan 28;275(4):2661-8
pubmed: 10644727
Biotechniques. 2004 Mar;36(3):402-4, 406
pubmed: 15038154
FEBS J. 2011 Jan;278(1):28-45
pubmed: 21087458
Cardiovasc Res. 2006 Feb 15;69(3):562-73
pubmed: 16405877
Methods Mol Biol. 2019;1952:201-210
pubmed: 30825176
Neurobiol Dis. 2012 Dec;48(3):508-18
pubmed: 22885251
Cell. 2010 Apr 2;141(1):52-67
pubmed: 20371345
Matrix Biol. 2007 Oct;26(8):587-96
pubmed: 17669641
J Biol Chem. 1992 Apr 5;267(10):6776-81
pubmed: 1313021
Anat Rec (Hoboken). 2012 Sep;295(9):1415-20
pubmed: 22807344
Invest Ophthalmol Vis Sci. 2014 Mar 28;55(3):1953-64
pubmed: 24681977
Arch Biochem Biophys. 1998 Jun 1;354(1):24-30
pubmed: 9633594
Cell Mol Life Sci. 2008 Apr;65(7-8):1073-85
pubmed: 18066495
Crit Rev Biochem Mol Biol. 2007 May-Jun;42(3):113-85
pubmed: 17562450
J Biol Chem. 2006 Jul 7;281(27):18626-37
pubmed: 16672230
PLoS One. 2011;6(6):e20616
pubmed: 21673806
Kidney Int. 1993 Jan;43(1):158-62
pubmed: 8433555
ScientificWorldJournal. 2013;2013:920595
pubmed: 23365550
Biochemistry. 2009 Nov 24;48(46):10830-45
pubmed: 19817485
Front Oncol. 2014 Jan 13;3:327
pubmed: 24455486
Connect Tissue Res. 2008;49(3):180-4
pubmed: 18661338
J Biol Chem. 2016 May 27;291(22):11751-60
pubmed: 27044750
J Biol Chem. 2002 Dec 27;277(52):50326-32
pubmed: 12384502
J Immunol. 2011 Nov 15;187(10):4927-33
pubmed: 22049227
Biochem J. 2015 Jan 15;465(2):259-70
pubmed: 25360794
J Cell Biol. 2005 May 23;169(4):681-91
pubmed: 15911882
Blood. 1993 Nov 1;82(9):2880-9
pubmed: 8219236
Methods Enzymol. 1995;248:470-84
pubmed: 7674939
J Mol Biol. 2004 Mar 19;337(2):367-86
pubmed: 15003453
Biochem J. 2005 Nov 15;392(Pt 1):127-34
pubmed: 16008524
J Biol Chem. 2008 May 16;283(20):13652-65
pubmed: 18359769
FEBS J. 2011 Jan;278(1):16-27
pubmed: 21087457
Crit Rev Biochem Mol Biol. 2010 Oct;45(5):351-423
pubmed: 20812779
FEBS J. 2013 Jun;280(12):2870-87
pubmed: 23601700
Integr Biol (Camb). 2009 Jun;1(5-6):404-26
pubmed: 20023747
Matrix Biol. 2015 May-Jul;44-46:255-63
pubmed: 25701651
Structure. 2007 Oct;15(10):1227-36
pubmed: 17937912
Biochim Biophys Acta. 2010 Jan;1803(1):39-54
pubmed: 19800373
PLoS One. 2012;7(6):e39918
pubmed: 22768169
J Leukoc Biol. 2000 Feb;67(2):183-8
pubmed: 10670578
J Biol Chem. 1994 Mar 4;269(9):6632-6
pubmed: 8120015
Eur J Biochem. 2003 Oct;270(19):3996-4007
pubmed: 14511382
Neural Regen Res. 2014 Feb 15;9(4):362-76
pubmed: 25206824
Front Biosci. 2006 Jan 01;11:544-69
pubmed: 16146752
Matrix Biol. 2015 May-Jul;44-46:191-9
pubmed: 25622911
J Biol Chem. 2012 Apr 20;287(17):14122-35
pubmed: 22351750
Anal Biochem. 2001 Jun 1;293(1):38-42
pubmed: 11373076
J Biol Chem. 1992 Mar 5;267(7):4583-91
pubmed: 1311314
Anal Biochem. 1989 Nov 1;182(2):319-26
pubmed: 2610349

Auteurs

Rangita Dawadi (R)

Department of Medical Biology, Faculty of Health Sciences, UiT-The Arctic University of Norway, 9037 Tromsø, Norway.

Nabin Malla (N)

Department of Medical Biology, Faculty of Health Sciences, UiT-The Arctic University of Norway, 9037 Tromsø, Norway.

Beate Hegge (B)

Department of Medical Biology, Faculty of Health Sciences, UiT-The Arctic University of Norway, 9037 Tromsø, Norway.

Imin Wushur (I)

Department of Medical Biology, Faculty of Health Sciences, UiT-The Arctic University of Norway, 9037 Tromsø, Norway.

Eli Berg (E)

Department of Medical Biology, Faculty of Health Sciences, UiT-The Arctic University of Norway, 9037 Tromsø, Norway.

Gunbjørg Svineng (G)

Department of Medical Biology, Faculty of Health Sciences, UiT-The Arctic University of Norway, 9037 Tromsø, Norway.

Ingebrigt Sylte (I)

Department of Medical Biology, Faculty of Health Sciences, UiT-The Arctic University of Norway, 9037 Tromsø, Norway.

Jan-Olof Winberg (JO)

Department of Medical Biology, Faculty of Health Sciences, UiT-The Arctic University of Norway, 9037 Tromsø, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH